Advertisement

The Scientist

» nanoscale imaging and disease/medicine

Most Recent

image: Punch Drunk

Punch Drunk

By | December 1, 2011

After a concussion forces him to retire, a former pro-wrestler starts an institute to study the neurological effects of repeated brain injuries.

18 Comments

image: Lipitor Patent Expires

Lipitor Patent Expires

By | November 30, 2011

The pharmaceutical darling that has brought billions in revenue to Pfizer over the past 15 years will now share the shelves with its generic competitors.

0 Comments

image: Nanomagnets Clean Blood?

Nanomagnets Clean Blood?

By | November 30, 2011

A magnetic nanoparticle is being designed to help draw toxins out of the bloodstream.

0 Comments

image: Cancer’s Escape Routes

Cancer’s Escape Routes

By | November 30, 2011

Scientists are beginning to discover myriad strategies tumors use to avoid attacks by anti-cancer drugs.

18 Comments

image: Psychopathic Pathology

Psychopathic Pathology

By | November 28, 2011

The brains of psychopaths have a different structure than healthy brains, perhaps explaining their antisocial and impulsive behaviors.

0 Comments

image: Mikovits Extradition Delayed

Mikovits Extradition Delayed

By | November 23, 2011

The controversial chronic fatigue researcher will not be extradited to face felony charges for at least a month.

0 Comments

image: A Spoonful of Sugar

A Spoonful of Sugar

By | November 23, 2011

A special glucose molecule makes tumor cells more vulnerable to a pair of cancer cell-killing drugs.

3 Comments

image: An Obesity-Cancer Link?

An Obesity-Cancer Link?

By | November 22, 2011

Why obese individual are more likely to get cancer could be partly explained by a gene that activates both pathways.

3 Comments

image: Top 7 in Genomics & Genetics

Top 7 in Genomics & Genetics

By | November 22, 2011

A snapshot of the most highly ranked articles in genomics, genetics and related areas, from Faculty of 1000

0 Comments

image: Genentech Plans New Avastin Trial

Genentech Plans New Avastin Trial

By | November 21, 2011

After the FDA revoked its approval of Avastin for the treatment of metastatic breast cancer, the drug maker says it will initiate new trials.

3 Comments

Follow The Scientist

icon-facebook icon-linkedin icon-twitter icon-vimeo icon-youtube
Advertisement

Stay Connected with The Scientist

  • icon-facebook The Scientist Magazine
  • icon-facebook The Scientist Careers
  • icon-facebook Neuroscience Research Techniques
  • icon-facebook Genetic Research Techniques
  • icon-facebook Cell Culture Techniques
  • icon-facebook Microbiology and Immunology
  • icon-facebook Cancer Research and Technology
  • icon-facebook Stem Cell and Regenerative Science
Advertisement
The Scientist
The Scientist
Advertisement
The Scientist
The Scientist